Innate Pharma
Price & Volume
Stats
See more52W Range | $1.17-$2.71 |
Market Cap | $207.7M |
Shares Short | 81,961 |
Financials
See moreRevenue (12 Mos) | $9M |
Revenue Growth (YoY) | -46.7% |
Gross Profit (12 Mos) | -$34.6M |
Diluted EPS | -$0.59 |
News
See moreYahoo Finance • 5 days ago
Innate Pharma Q2 Earnings Call Highlights
Yahoo Finance • 6 days ago
Innate Pharma gives H1 results
Yahoo Finance • 6 days ago
Innate Pharma Reports First Half 2026 Business Update and Financial Results
Yahoo Finance • 6 days ago
Sobi and Innate announce partnership is now effective following completion of closing conditions
About
CEO | Mr. Jonathan E. Dickinson B.Sc., M.B.A. |
CFO | Mr. Frederic Lombard M.B.A. |
Address | 117, Avenue de Luminy, Marseille, France, 13009 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 164 |